Ftse Mib
36.059,17
-0,23%
DAX
21.042,00
0,18%
S&P 500
6.049,24
0,88%
NASDAQ
19.756,78
0,64%
Bitcoin
105.569,37
-0,57%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ PainReform Ltd (PRFX) PainReform Ltd (PRFX) Notizie

PainReform Ltd

PRFX
3,02
0,00 (0,00%)
22 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/1/202522:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/1/202522:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/12/202414:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/12/202414:30GLOBEPainReform Provides Further Update on Phase 3 Clinical Trial..
13/12/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
12/12/202423:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/12/202422:30EDGAR2Form F-3 - Registration statement by foreign private issuers
04/12/202422:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202414:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202414:30GLOBEPainReform Announces Initial Topline Data for PRF-110 Phase..
18/11/202423:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/11/202414:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202423:00GLOBEPainReform Announces Receipt of Nasdaq Notice Regarding..
07/11/202422:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/11/202422:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/10/202422:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/10/202422:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/10/202423:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/9/202422:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/9/202422:30EDGAR2Form F-3 - Registration statement by foreign private issuers
11/9/202415:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202414:30GLOBEPainReform Ltd. Confirms Sutures Compatibility in Human..
10/9/202415:46GLOBEPainReform Announces Exercise of Warrants for $1.58 Million..
10/9/202415:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/9/202422:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202422:30EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
27/8/202423:07EDGAR2Form POS AM - Post-Effective amendments for registration..
26/8/202423:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/8/202414:30GLOBEPainReform Bunionectomy Study Observations Confirm Optimal..
20/8/202414:30GLOBEPainReform Announces Positive Safety Profile for PRF-110 in..
15/8/202422:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202414:00GLOBEPainReform Provides Business Update for the Second Quarter..
13/8/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/8/202415:00GLOBEPainReform Announces Development and Successful..
07/8/202416:00GLOBEPainReform Announces Favorable Safety Profile of PRF-110,..
05/8/202415:00GLOBEPainReform Ltd. Announces Favorable Wound Healing Data in..
01/8/202414:30GLOBEPainReform’s New Manufacturing Process Achieves Significant..
24/7/202414:30GLOBEPainReform Files Patent Covering Highly Scalable..
09/7/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/6/202414:00GLOBEPainReform Completes Enrollment in the Second Part of its..
31/5/202422:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/5/202422:15GLOBEPainReform Announces Receipt of Nasdaq Minimum Bid Price..
15/5/202422:05GLOBEPainReform Provides Business Update for the First Quarter of..
08/5/202414:30GLOBEPainReform CEO Ilan Hadar Discusses Latest Developments..
18/4/202420:19GLOBEPainReform Announces Closing of $4 Million Public Offering
16/4/202414:00GLOBEPainReform Announces Pricing of $4 Million Public Offering
09/4/202415:00GLOBEPainReform’s Non-Opiate Topical Treatment for Post-Surgical..
02/4/202414:30GLOBEPainReform Reaches 50% Enrollment in the Second Part of its..
07/3/202423:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202422:34EDGAR2Form F-1 - Registration statement for certain foreign..
Apertura: 2,96 Min: 2,90 Max: 3,06
Chiusura: 3,02

La tua Cronologia

NASDAQ
PRFX
PainReform
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network